Literature DB >> 17714534

Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.

Tsukasa Kirimoto1, Koushi Nakano, Kenji Irimura, Yukio Hayashi, Naosuke Matsuura, Mamoru Kiniwa, Toshinori Oka, Naoki Yoshimura.   

Abstract

OBJECTIVE: To examine the effects of suplatast tosilate (IPD-1151T), a Th2 cytokine inhibitor recently recognized to improve the symptoms in patients with interstitial cystitis (IC), in a rat model of HCl-induced chronic cystitis, to elucidate the possible mechanisms by which the drug improves the symptoms of IC.
MATERIALS AND METHODS: Chronic cystitis was induced by intravesical instillation of 0.2 mL of 0.4 m HCl in female adult rats. After a once-daily oral administration of IPD-1151T (0.1-100 mg/kg) or prednisolone (5 mg/kg) for 7 days, cystometry was performed under urethane anaesthesia. The bladder from HCl-induced cystitis rats was also assessed histopathologically.
RESULTS: On cystometrography there was frequent voiding in cystitis rats. Administration of IPD-1151T for 7 days after intravesical HCl instillation dose-dependently increased the micturition volume and intercontraction intervals. Treatment with prednisolone had similar therapeutic effects. Histological analyses in the bladder from cystitis rats revealed oedema and infiltration of inflammatory cells such as mast cells and eosinophils in the lamina propria and the transitional epithelial thickening. These histological changes and the number of mast cells and eosinophils were reduced by administration of IPD-1151T or prednisolone.
CONCLUSION: The present results indicate that IPD-1151T improves bladder function and pathological changes in HCl-induced cystitis rats, as previously observed in patients with IC. The rat cystitis model induced by HCl could provide useful information for studying proposed therapies for IC which might involve T cell-dependent inflammatory responses as one of its potential pathophysiologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714534     DOI: 10.1111/j.1464-410X.2007.07044.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis.

Authors:  Yukio Hayashi; Koichi Takimoto; Michael B Chancellor; Kristin A Erickson; Vickie L Erickson; Tsukasa Kirimoto; Koushi Nakano; William C de Groat; Naoki Yoshimura
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

2.  Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.

Authors:  W F Goins; J R Goss; M B Chancellor; W C de Groat; J C Glorioso; N Yoshimura
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

3.  A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.

Authors:  Susan Keay; Samantha Leitzell; Ashley Ochrzcin; George Clements; Min Zhan; David Johnson
Journal:  BMC Urol       Date:  2012-06-08       Impact factor: 2.264

4.  Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis.

Authors:  Phil Hyun Song; So Young Chun; Jae-Wook Chung; Yeon Yong Kim; Hyo Jung Lee; Jun Nyung Lee; Yun-Sok Ha; Eun Sang Yoo; Tae Gyun Kwon; Jeongshik Kim; Dae Hwan Kim; Bum Soo Kim
Journal:  Int Neurourol J       Date:  2017-09-12       Impact factor: 2.835

5.  Diagnosis in a Preclinical Model of Bladder Pain Syndrome Using a Au/ZnO Nanorod-based SERS Substrate.

Authors:  Sanghwa Lee; Jung-Man Namgoong; Hwan Yeul Yu; Miyeon Jue; Gwanho Kim; Sangmin Jeon; Dong-Myung Shin; Myung-Soo Choo; Jinmyoung Joo; Chan-Gi Pack; Jun Ki Kim
Journal:  Nanomaterials (Basel)       Date:  2019-02-07       Impact factor: 5.076

Review 6.  Animal Modelling of Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Int Neurourol J       Date:  2018-01-31       Impact factor: 2.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.